182 related items for PubMed ID: 34044395
1. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Espinosa Reyes TM, Leyva González G, Domínguez Alonso E, Falhammar H.
Horm Res Paediatr; 2021; 94(1-2):1-8. PubMed ID: 34044395
[Abstract] [Full Text] [Related]
2. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
Elnecave RH, Kopacek C, Rigatto M, Keller Brenner J, Sisson de Castro JA.
J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
[Abstract] [Full Text] [Related]
3. Bone density in young patients with congenital adrenal hyperplasia.
Mora S, Saggion F, Russo G, Weber G, Bellini A, Prinster C, Chiumello G.
Bone; 1996 Apr; 18(4):337-40. PubMed ID: 8726391
[Abstract] [Full Text] [Related]
4. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
Ganesh R, Suresh N, Janakiraman L, Ravikumar K.
Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
[Abstract] [Full Text] [Related]
5. Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency.
Lee DH, Kong SH, Jang HN, Ahn CH, Lim SG, Lee YA, Kim SW, Kim JH.
Arch Osteoporos; 2022 Mar 08; 17(1):45. PubMed ID: 35258698
[Abstract] [Full Text] [Related]
6. Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd-LIFE study.
Riehl G, Reisch N, Roehle R, Claahsen van der Grinten H, Falhammar H, Quinkler M.
Clin Endocrinol (Oxf); 2020 Apr 08; 92(4):284-294. PubMed ID: 31886890
[Abstract] [Full Text] [Related]
7. Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Ceccato F, Barbot M, Albiger N, Zilio M, De Toni P, Luisetto G, Zaninotto M, Greggio NA, Boscaro M, Scaroni C, Camozzi V.
Eur J Endocrinol; 2016 Aug 08; 175(2):101-6. PubMed ID: 27185866
[Abstract] [Full Text] [Related]
8. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
Sahakitrungruang T, Wacharasindhu S, Supornsilchai V, Srivuthana S, Kingpetch K.
J Med Assoc Thai; 2008 May 08; 91(5):705-10. PubMed ID: 18672636
[Abstract] [Full Text] [Related]
9. Normal bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.
Borges JH, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra-Júnior G, Gonçalves EM.
Osteoporos Int; 2022 Jan 08; 33(1):283-291. PubMed ID: 34406442
[Abstract] [Full Text] [Related]
10. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
Guo CY, Weetman AP, Eastell R.
Clin Endocrinol (Oxf); 1996 Nov 08; 45(5):535-41. PubMed ID: 8977749
[Abstract] [Full Text] [Related]
11. Bone mineral density and body composition in children with congenital adrenal hyperplasia.
Halper A, Sanchez B, Hodges JS, Kelly AS, Dengel D, Nathan BM, Petryk A, Sarafoglou K.
Clin Endocrinol (Oxf); 2018 Jun 08; 88(6):813-819. PubMed ID: 29460378
[Abstract] [Full Text] [Related]
12. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
J Clin Endocrinol Metab; 1995 Jul 08; 80(7):2238-43. PubMed ID: 7608286
[Abstract] [Full Text] [Related]
13. [Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry].
Romanowska H, Krzywińska-Zdeb E, Giżewska M, Kotkowiak L, Safranow K, Horodnicka-Józwa A, Petriczko E, Krupa B, Walczak M.
Pediatr Endocrinol Diabetes Metab; 2012 Jul 08; 18(1):21-6. PubMed ID: 22525687
[Abstract] [Full Text] [Related]
14. Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
El-Maouche D, Collier S, Prasad M, Reynolds JC, Merke DP.
Clin Endocrinol (Oxf); 2015 Mar 08; 82(3):330-7. PubMed ID: 24862755
[Abstract] [Full Text] [Related]
15. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
Koetz KR, Ventz M, Diederich S, Quinkler M.
J Clin Endocrinol Metab; 2012 Jan 08; 97(1):85-92. PubMed ID: 21994966
[Abstract] [Full Text] [Related]
16. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
Falhammar H, Filipsson Nyström H, Wedell A, Brismar K, Thorén M.
Eur J Endocrinol; 2013 Mar 08; 168(3):331-41. PubMed ID: 23211577
[Abstract] [Full Text] [Related]
17. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K.
Clin Endocrinol (Oxf); 2019 Jul 08; 91(1):124-130. PubMed ID: 31070802
[Abstract] [Full Text] [Related]
18. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
Ünal S, Alikaşifoğlu A, Özön A, Gönç N, Kandemir N.
Turk J Pediatr; 2020 Jul 08; 62(3):359-366. PubMed ID: 32558409
[Abstract] [Full Text] [Related]
19. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S.
J Clin Endocrinol Metab; 2006 Nov 08; 91(11):4453-8. PubMed ID: 16926248
[Abstract] [Full Text] [Related]
20. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M.
J Clin Endocrinol Metab; 2007 Dec 08; 92(12):4643-9. PubMed ID: 17878254
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
